Look At Analyst Expectations For A Better Read On Arbutus Biopharma Corp (NASDAQ: ABUS)
Currently, there are 189.44M common shares owned by the public and among those 147.43M shares have been available to trade. The company’s stock has a 5-day price change of -4.08% and -9.62% over the past three months. ABUS shares are trading 0.61% year to date (YTD), with the 12-month market performance up to 13.84% higher. […]
Arbutus Biopharma Corp (ABUS) Outlook Starting To Look Brighter?
Arbutus Biopharma Corp (ABUS) concluded trading on Thursday at a closing price of $2.54, with 4.33 million shares of worth about $11.01 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 25.12% during that period and on Thursday the price saw a gain of […]
